<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD>
<META http-equiv=Content-Type content="text/html; charset=windows-1252">
<STYLE>.hmmessage P {
PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 0px
}
BODY.hmmessage {
FONT-SIZE: 10pt; FONT-FAMILY: Tahoma
}
</STYLE>
<META content="MSHTML 6.00.2900.3603" name=GENERATOR></HEAD>
<BODY class=hmmessage bgColor=#ffffff>
<DIV>I fully agree with the idea and this is to express our support Leishmania
pathology network, we are<BR>interested to participate and help pushing this
idea forward. I will prepare <BR>support letter from our group will be send to
you as soon as possible.</DIV>
<DIV> </DIV>
<DIV><FONT face=Arial>Dr. Basu Dev Pandey, MD, PhD<BR>Everest International
Clinic and Research Center <BR>Kathmandu, Nepal<BR>Tel: 977-1-4253395<BR>Email:
<A
href="mailto:basupandey@wlink.com.np">basupandey@wlink.com.np</A></FONT><BR></DIV>
<BLOCKQUOTE
style="PADDING-RIGHT: 0px; PADDING-LEFT: 5px; MARGIN-LEFT: 5px; BORDER-LEFT: #000000 2px solid; MARGIN-RIGHT: 0px">
<DIV style="FONT: 10pt arial">----- Original Message ----- </DIV>
<DIV
style="BACKGROUND: #e4e4e4; FONT: 10pt arial; font-color: black"><B>From:</B>
<A title=jayusp@hotmail.com href="mailto:jayusp@hotmail.com">jeffrey shaw</A>
</DIV>
<DIV style="FONT: 10pt arial"><B>To:</B> <A title=leish-l@lineu.icb.usp.br
href="mailto:leish-l@lineu.icb.usp.br">Leish-L</A> </DIV>
<DIV style="FONT: 10pt arial"><B>Sent:</B> Tuesday, August 09, 2011 8:26
PM</DIV>
<DIV style="FONT: 10pt arial"><B>Subject:</B> [Leish-l] FW: Leishmaniasis
Pathology Network</DIV>
<DIV><BR></DIV>
<DIV dir=ltr><BR><BR>
<DIV>
<HR id=stopSpelling>
Date: Tue, 9 Aug 2011 11:58:52 +0100<BR>From: <A
href="mailto:paul.kaye@york.ac.uk">paul.kaye@york.ac.uk</A><BR><BR>Subject:
Leishmaniasis Pathology Network<BR><BR>
<META content="Microsoft SafeHTML" name=Generator>
<STYLE>
.ExternalClass p.ecxMsoNormal, .ExternalClass li.ecxMsoNormal, .ExternalClass div.ecxMsoNormal
{margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;font-size:12.0pt;font-family:'Times New Roman';color:black;}
.ExternalClass a:link, .ExternalClass span.ecxMsoHyperlink
{color:blue;text-decoration:underline;text-underline:single;}
.ExternalClass a:visited, .ExternalClass span.ecxMsoHyperlinkFollowed
{color:purple;text-decoration:underline;text-underline:single;}
.ExternalClass .ecxMsoChpDefault
{font-family:Cambria;}
.ExternalClass .ecxMsoPapDefault
{margin-bottom:10.0pt;}
@page WordSection1
{size:595.0pt 842.0pt;}
.ExternalClass div.ecxWordSection1
{page:WordSection1;}
</STYLE>
<P class=ecxMsoNormal>Dear all,</P>
<P class=ecxMsoNormal>Invitation to participate in a global pathology network
for research and training in leishmaniasis (LeishPathNet)</P>
<P class=ecxMsoNormal>You may recall the Dormy House meeting in 2008 and some
of the plans we put forward?<SPAN> </SPAN>Over the past couple years, I
have also spoken more to a few of you about one idea that was formulated at
Dormy, namely of setting up a digital pathology network. I have also had
numerous discussions with the major equipment manufacturers to see if any of
them would be supportive of helping us to develop such an
initiative.<SPAN> </SPAN>There have been two major develoments
recently.<SPAN> </SPAN>First, Carl Zeiss is willing to work with us to
set up an integrated global digital pathology network (providing a significant
financial and technical contribution) and second, the Wellcome Trust is
willing to review a pre-proposal to fund the initiative through their new
Biomedical Resources Grant scheme (<A
href="http://www.wellcome.ac.uk/Funding/Biomedical-science/Funding-schemes/Strategic-awards-and-initiatives/wtdv031727.htm"
target=_blank>http://www.wellcome.ac.uk/Funding/Biomedical-science/Funding-schemes/Strategic-awards-and-initiatives/wtdv031727.htm</A>)
.</P>
<P class=ecxMsoNormal>I have attached an outline of the project that I had
sent to the Trust for their initial views, which I think is reasonably
self-explanatory. <SPAN> </SPAN>They appeared very
enthusiastic!<SPAN> </SPAN>The main question now is whether enough of
you are still supportive? [ I will also be sending this email to others, but
please feel free to circulate ]<BR></P>
<P class=ecxMsoNormal><SPAN>I think the project will be challenging, but
success could have a real impact on the way we conduct business. It
should serve not only as a vehicle to enhance research in leishmaniasis, but
the model would be equally applicable across a broad range of diseases and
global challenges (with leishmaniasis setting the pace).</SPAN></P>
<P class=ecxMsoNormal><SPAN>If we wish to proceed, the requirements are that
we submit a pre-proposal to the Trust by <B>Oct 18<SUP>th</SUP>
2011</B>.<SPAN> </SPAN>This pre-proposal is short (4 sections of 350
words) and requires letters of support from the community.<SPAN>
</SPAN><SPAN> </SPAN></SPAN></P>
<P class=ecxMsoNormal><SPAN>If you are supportive of the idea that we try to
take this forward (and there is plenty of scope for later iteration of the
detail), I would be grateful if you could please provide me with a letter of
support by <B>September 12<SUP>th</SUP> 2011, </B>indicating whether you would
like to be a network partner if the bid is successful.<SPAN> </SPAN>You
could also be supportive but not wish to become directly involved at this
stage, and such letters are equally valuable. Your letter might also stress
the added value that the network could provide, its importance for research
and training and/or for progressing the translational agenda.<SPAN>
</SPAN>It would also be an opportunity to indicate whether your group (or
institute, if multiple groups) would be interested in bidding to be one of the
initial ‘designated laboratories’. <SPAN> </SPAN></SPAN></P>
<P class=ecxMsoNormal><SPAN>If there is sufficient support to proceed and if
subsequently the pre-proposal is successful (we will know on 22<SUP>nd</SUP>
Nov), then I will need a few volunteers to help finalise the full proposal,
which will be due on Jan 26<SUP>th</SUP> 2012.<SPAN> </SPAN>A funding
decision will be made on May 26<SUP>th</SUP> 2012. </SPAN></P>
<P class=ecxMsoNormal><SPAN>Best wishes and of course I am happy to discuss
any points further (though I will be out of the UK from Aug 10 –Sept
12)</SPAN></P>
<P class=ecxMsoNormal><SPAN>Paul</SPAN></P>
<P class=ecxMsoNormal><SPAN></SPAN> </P><BR><BR><BR><PRE class=ecxmoz-signature>--
Professor Paul Kaye, Ph.D., FRCPath.
Deputy Dean (Research), Hull York Medical School, and
Director, Centre for Immunology and Infection
Department of Biology and Hull York Medical School
University of York
Wentworth Way
York YO10 5YW
United Kingdom
Tel: +44 (0)1904 328840
Fax: +44 (0)1904 328844
Email: <A class=ecxmoz-txt-link-abbreviated href="mailto:paul.kaye@york.ac.uk">paul.kaye@york.ac.uk</A> <A class=ecxmoz-txt-link-rfc2396E href="mailto:paul.kaye@york.ac.uk"><mailto:paul.kaye@york.ac.uk></A>
Centre Administrator and PA: Elizabeth Greensted
Tel: 01904 328845
Email: <A class=ecxmoz-txt-link-abbreviated href="mailto:liz.greensted@york.ac.uk">liz.greensted@york.ac.uk</A> <A class=ecxmoz-txt-link-rfc2396E href="mailto:liz.greensted@york.ac.uk"><mailto:liz.greensted@york.ac.uk></A>
Centre Email: <A class=ecxmoz-txt-link-abbreviated href="mailto:cii@york.ac.uk">cii@york.ac.uk</A> <A class=ecxmoz-txt-link-rfc2396E href="mailto:cii@york.ac.uk"><mailto:cii@york.ac.uk></A>
Centre website: <A class=ecxmoz-txt-link-freetext href="http://www.york.ac.uk/cii" target=_blank>http://www.york.ac.uk/cii</A>
Times Higher Education University of the Year 2010
Email disclaimer: <A class=ecxmoz-txt-link-freetext href="http://www.york.ac.uk/docs/disclaimer/email.htm" target=_blank>http://www.york.ac.uk/docs/disclaimer/email.htm</A>
</PRE></DIV></DIV>
<P>
<HR>
<P></P>_______________________________________________<BR>Leish-l mailing
list<BR>Leish-l@lineu.icb.usp.br<BR>http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l<BR></BLOCKQUOTE></BODY></HTML>